Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9627)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu QQ, Qiu H, Zhang MS, Hu GY, Liu B, Huang L, Liao X, Li QX, Li ZH, Yuan XL. Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy. World J Gastroenterol 2016; 22(16): 4250-4258 [PMID: 27122675 DOI: 10.3748/wjg.v22.i16.4250] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i16/4250.htm |
| Number | Citing Articles |
| 1 |
Huiling Sun, Bangshun He, Zhenlin Nie, Yuqin Pan, Kang Lin, Hongxin Peng, Tao Xu, Xiaoxiang Chen, Xiuxiu Hu, Zijuan Wu, Di Wu, Shukui Wang. A nomogram based on serum bilirubin and albumin levels predicts survival in gastric cancer patients. Oncotarget 2017; 8(25): 41305 doi: 10.18632/oncotarget.17181
|
| 2 |
Qunfeng Zhang, Xiaowei Ma, Qunhuan Xu, Juanxiu Qin, Yanhua Wang, Qian Liu, Hua Wang, Min Li. Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection. Oncotarget 2017; 8(41): 71138 doi: 10.18632/oncotarget.11424
|
| 3 |
Evgeny N. Imyanitov, Aglaya G. Iyevleva. Molecular tests for prediction of tumor sensitivity to cytotoxic drugs. Cancer Letters 2022; 526: 41 doi: 10.1016/j.canlet.2021.11.021
|
| 4 |
Qianqian Yu, Tao Zhang, Conghua Xie, Hong Qiu, Bo Liu, Liu Huang, Ping Peng, Jueping Feng, Jigui Chen, Aihua Zang, Xianglin Yuan. UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy. Cancer Chemotherapy and Pharmacology 2018; 82(1): 87 doi: 10.1007/s00280-018-3595-7
|
| 5 |
Ljerka Prester, Anja Mikolić, Andreja Jurič, Nino Fuchs, Marijana Neuberg, Ana Lucić Vrdoljak, Irena Brčić Karačonji. Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats. Chemico-Biological Interactions 2018; 294: 128 doi: 10.1016/j.cbi.2018.08.009
|
| 6 |
Maheboob Basade, Akshata Mane. Optimum patient selection for irinotecan-containing regimens in metastatic colorectal cancer: Literature review and lessons from clinical practice. Indian Journal of Cancer 2021; 58(1): 5 doi: 10.4103/ijc.IJC_507_19
|
| 7 |
Yaoxian Xiang, Chan Zhang, Jing Wang, Yurong Cheng, Kangjie Wang, Li Wang, Yingying Tong, Dong Yan. Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04686-9
|
| 8 |
Shenyun Shi, Yin Liu, Xiaohua Qiu, Min Cao, Yonglong Xiao, Xin Yan. Correlation between serum bilirubin levels and the severity as well as the prognosis of idiopathic pulmonary fibrosis. Chronic Respiratory Disease 2020; 17 doi: 10.1177/1479973120957676
|